Target intelligence / Profile preview

Mitochondrial NADH:ubiquinone oxidoreductase (Complex I)

Target
Complex I
Molecular classification
Enzyme, Electron transport chain complex, Oxidoreductase
01

Overview

Mitochondrial NADH:ubiquinone oxidoreductase (Complex I) is the largest and first enzyme complex of the mitochondrial respiratory chain, located in the inner mitochondrial membrane. It catalyzes the oxidation of NADH to NAD⁺ and transfers electrons to ubiquinone (coenzyme Q10), coupled to the translocation of protons across the membrane. This process is essential for oxidative phosphorylation and ATP production. Complex I is composed of 44 subunits in mammals and plays key roles in cellular energy metabolism, generation of mitochondrial membrane potential, and regulation of oxidative stress. Mutations or dysfunctions in this complex are implicated in numerous human diseases including mitochondrial encephalopathies, Parkinson’s disease, and cardiac and neurological disorders linked to oxidative stress and impaired energy metabolism[1][3][4][5][6][7][9].

Other names
Respiratory complex IType I NADH dehydrogenaseMitochondrial complex IEC 7.1.1.2
02

Mechanism of action

Inhibition of electron transfer, Disruption of proton translocation, Modulation of ROS production

03

Biological functions

Cellular respirationATP synthesisOxidative phosphorylationNADH oxidationReactive oxygen species productionApoptosis
04

Disease associations

Mitochondrial diseaseLeigh syndromeLeber’s hereditary optic neuropathyParkinson’s diseaseIschemia/reperfusion injuryNeurodegenerative diseaseCardiac disease
05

Safety considerations

Potential for lactic acidosisNeurotoxicityCardiotoxicityIncreased reactive oxygen species and oxidative stressEnergy crisis in susceptible tissueMitochondrial toxicity
06

Interacting drugs

Rotenone

5 more in the full profile.

07

Biomarkers

Mutations in mitochondrial DNA-encoded complex I subunits (e.g., MT-ND1 through MT-ND6, MT-ND4L)Complex I activity assaysLactate/pyruvate ratio (in some mitochondrial diseases)

Beyond the preview

Go deeper on Mitochondrial NADH:ubiquinone oxidoreductase (Complex I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial NADH:ubiquinone oxidoreductase (Complex I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call